Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome

被引:8
|
作者
Ait-Abdesselam, Tassadit [1 ]
Lequerre, Thierry [1 ]
Legallicier, Bruno [2 ]
Francois, Arnaud [3 ]
Loet, Xavier Le [1 ]
Vittecoq, Olivier [1 ]
机构
[1] Rouen Univ Hosp, Dept Rheumatol, Inst Biomed Res, Inserm U905, F-76031 Rouen, France
[2] Rouen Univ Hosp, Dept Nephrol, F-76031 Rouen, France
[3] Rouen Univ Hosp, Dept Anatomopathol, F-76031 Rouen, France
关键词
Anakinra; Renal AA amyloidosis; Cryopyrin-associated periodic syndrome; INTERLEUKIN-1 RECEPTOR ANTAGONIST; COLD AUTOINFLAMMATORY SYNDROME; MUCKLE-WELLS-SYNDROME;
D O I
10.1016/j.jbspin.2010.04.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:616 / 617
页数:2
相关论文
共 50 条
  • [41] Interleukin-1 beta inhibitors for the treatment of cryopyrin-associated periodic syndrome
    Dhimolea, Eugen
    APPLICATION OF CLINICAL GENETICS, 2011, 4 : 21 - 27
  • [42] Inhibition of the NF-κB pathway as a candidate therapeutic strategy for cryopyrin-associated periodic syndrome
    Shimogaki, Satoka
    Ito, Sayaka
    Komatsu, Sachiyo
    Koike, Ryuji
    Miyasaka, Nobuyuki
    Umezawa, Kazuo
    Kubota, Tetsuo
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 517 - 524
  • [43] A Patient with a Phenotype of Adult-onset Still Disease, But a Genotype Typical of Cryopyrin-associated Periodic Fever Syndrome
    Eriksson, Per
    Jacobs, Claudia
    Soderkvist, Peter
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (09) : 1632 - 1634
  • [44] Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study
    Mulders-Manders, Catharina M.
    Kanters, Tim A.
    van Daele, Paul L. A.
    Hoppenreijs, Esther
    Legger, G. Elizabeth
    van Laar, Jan A. M.
    Simon, Anna
    Hakkaart-van Roijen, Leona
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [45] Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study
    Catharina M. Mulders-Manders
    Tim A. Kanters
    Paul L. A. van Daele
    Esther Hoppenreijs
    G. Elizabeth Legger
    Jan A. M. van Laar
    Anna Simon
    Leona Hakkaart-van Roijen
    Orphanet Journal of Rare Diseases, 13
  • [46] Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades
    Eskola, Vesa
    Pohjankoski, Heini
    Kroeger, Liisa
    Aalto, Kristiina
    Latva, Katariina
    Korppi, Matti
    ACTA PAEDIATRICA, 2018, 107 (04) : 577 - 580
  • [47] Cryopyrin-associated periodic syndrome (CAPS) in a patient with NLRP3 T348M mutation
    Kreft, Burkhard
    Schlinsog, Anne-Sophie
    Wohlrab, Johannes
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (10): : 1266 - 1268
  • [48] Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome
    Matsuda, Tomoko
    Takimoto-Ito, Riko
    Lipsker, Dan
    Kambe, Naotomo
    ALLERGOLOGY INTERNATIONAL, 2023, 72 (03) : 385 - 393
  • [49] Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry
    Levy, R.
    Gerard, L.
    Kuemmerle-Deschner, J.
    Lachmann, H. J.
    Kone-Paut, I.
    Cantarini, L.
    Woo, P.
    Naselli, A.
    Bader-Meunier, B.
    Insalaco, A.
    AI-Mayoutl, S. M.
    Ozen, S.
    Hofer, M.
    Frenkel, J.
    Modesto, C.
    Nikishina, I.
    Schwarz, T.
    Martino, S.
    Meini, A.
    Quartier, P.
    Martini, A.
    Ruperto, N.
    Neven, B.
    Gattorno, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (11) : 2043 - 2049
  • [50] Cryopyrin-associated periodic syndrome in Australian children and adults: Epidemiological, clinical and treatment characteristics
    Mehr, Sam
    Allen, Roger
    Boros, Christina
    Adib, Navid
    Kakakios, Alyson
    Turner, Paul J.
    Rogers, Maureen
    Zurynski, Yvonne
    Singh-Grewal, Davinder
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2016, 52 (09) : 889 - 895